Cargando…

Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus

Glucagon-like peptide-1 (GLP-1) receptor agonists are recently discovered antidiabetic drugs with potent hypoglycemic effects. Among different mechanisms of activity, these compounds were shown to reduce blood glucose by suppression of glucagon secretion and stimulation of glucose-dependent insulin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaribeygi, Habib, Atkin, Stephen L., Montecucco, Fabrizio, Jamialahmadi, Tannaz, Sahebkar, Amirhossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405289/ https://www.ncbi.nlm.nih.gov/pubmed/34471642 http://dx.doi.org/10.1155/2021/8163153

Ejemplares similares

Impact of Incretin-Based Therapies on Adipokines and Adiponectin
por: Yaribeygi, Habib, et al.
Publicado: (2021)

The Impact of Incretin-Based Medications on Lipid Metabolism
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms
por: Yaribeygi, Habib, et al.
Publicado: (2021)

The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions
por: Yaribeygi, Habib, et al.
Publicado: (2020)

Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu
por: Yaribeygi, Habib, et al.
Publicado: (2022)

Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus
por: Yaribeygi, Habib, et al.
Publicado: (2020)

Molecular Mechanisms by Which Imeglimin Improves Glucose Homeostasis
por: Yaribeygi, Habib, et al.
Publicado: (2020)

Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Molecular mechanisms linking stress and insulin resistance
por: Yaribeygi, Habib, et al.
Publicado: (2022)

Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions: state of the art
por: Yaribeygi, Habib, et al.
Publicado: (2023)

Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
por: Yaribeygi, Habib, et al.
Publicado: (2023)

Brain insulin signaling and cognition: Possible links
por: Yaribeygi, Habib, et al.
Publicado: (2023)

The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptydilpeptidase-4 Inhibitors on Blood Pressure and Cardiovascular Complications in Diabetes
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Beneficial Effect of Statin Therapy on Arterial Stiffness
por: Alidadi, Mona, et al.
Publicado: (2021)

Potential Alteration of Statin-Related Pharmacological Features in Diabetes Mellitus
por: Mashayekhi-Sardoo, Habibeh, et al.
Publicado: (2021)

Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats
por: Yaribeygi, Habib, et al.
Publicado: (2023)

Effect of Curcumin on Attenuation of Liver Cirrhosis via Genes/Proteins and Pathways: A System Pharmacology Study
por: Mahmoudi, Ali, et al.
Publicado: (2022)

Harnessing the Therapeutic Potential of Decoys in Non-Atherosclerotic Cardiovascular Diseases: State of the Art
por: Mahjoubin-Tehran, Maryam, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
por: Mahjoubin-Tehran, Maryam, et al.
Publicado: (2020)

Statin Therapy in Post-Operative Atrial Fibrillation: Focus on the Anti-Inflammatory Effects
por: Nomani, Homa, et al.
Publicado: (2021)

Targeting AMPK by Statins: A Potential Therapeutic Approach
por: Dehnavi, Sajad, et al.
Publicado: (2021)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
por: Reiner, Željko, et al.
Publicado: (2020)

Update on Statin Treatment in Patients with Neuropsychiatric Disorders
por: Avan, Razieh, et al.
Publicado: (2021)

GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
por: Rezaei, Shahla, et al.
Publicado: (2021)

The positive short‐term effect of dexamethasone on ataxia symptoms in a patient with ataxia‐telangiectasia: A case report
por: Saberi‐Karimian, Maryam, et al.
Publicado: (2022)

The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study
por: Butler, Alexandra E., et al.
Publicado: (2023)

The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review
por: Moosavian, Seyedeh Alia, et al.
Publicado: (2021)

Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis
por: Mahmoudi, Ali, et al.
Publicado: (2021)

Renoprotective effects of incretin‐based drugs: A novel pleiotropic effect of dipeptidyl peptidase‐4 inhibitor
por: Kodera, Ryo, et al.
Publicado: (2015)

The effect of intravenous trehalose administration in a patient with multiple sulfatase deficiency
por: Radbakhsh, Shabnam, et al.
Publicado: (2023)

The Prevalence of Infectious Keratitis after Keratorefractive Surgery: A Systematic Review and Meta-Analysis Study
por: Afsharpaiman, Shahla, et al.
Publicado: (2020)

Impact of bariatric surgery on circulating PCSK9 levels as a marker of cardiovascular disease risk: a meta-analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Effects of Statins on Renin–Angiotensin System
por: Kiaie, Nasim, et al.
Publicado: (2021)

The Effect of Curcumin on the Differentiation of Mesenchymal Stem Cells into Mesodermal Lineage
por: Gorabi, Armita Mahdavi, et al.
Publicado: (2019)

Incretin - based therapy in diabetes mellitus: present scenario and expanding horizons
por: Kohli, Suresh Chandra
Publicado: (2016)

The Effects of Statin Treatment on Serum Ferritin Levels: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Harnessing Therapeutic Potentials of Statins Using Nanofibrous Carriers
por: Ataei, Mahshid, et al.
Publicado: (2021)

Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
por: Groeneveld, Onno N, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c0lg7j2pht6vap1ehhbn93jfvj